Immuron (IMRN) Intangibles (2022)
Immuron (IMRN) posted quarterly Intangibles of $102154.0 for Q2 2022.
Immuron (IMRN) Intangibles (2022) Analysis & Trends
Immuron (IMRN) has reported Intangibles for 1 consecutive years, with $102154.0 the latest figure, recorded in Q2 2022.
- Quarterly Intangibles changed N/A year-over-year to $102154.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $102154.0 (changed N/A YoY) and the FY2022 annual result came in at $102154.0, changed N/A from the prior year.
- Intangibles held at $102154.0 in Q2 2022 per IMRN's latest filing.
- Over the last five years, Intangibles for IMRN reached as high as $102154.0 in Q2 2022 and fell as low as $102154.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 102,153.99 |